fidarestat has been researched along with Acute Kidney Injury in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chung, S; Hibi, C; Kato, N; Mizukami, H; Nukada, H; Ogasawara, S; Yagihashi, S; Yamagishi, S | 1 |
Hibi, C; Inaba, W; Kamata, K; Kato, N; Mizukami, H; Takahashi, K; Yagihashi, S | 1 |
2 other study(ies) available for fidarestat and Acute Kidney Injury
Article | Year |
---|---|
The role of the polyol pathway in acute kidney injury caused by hindlimb ischaemia in mice.
Topics: Acute Kidney Injury; Aldehyde Reductase; Animals; Enzyme Inhibitors; Hindlimb; Imidazolidines; Ischemia; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Skeletal; Necrosis; Polymers; Signal Transduction | 2010 |
Amelioration of acute kidney injury in lipopolysaccharide-induced systemic inflammatory response syndrome by an aldose reductase inhibitor, fidarestat.
Topics: Acute Kidney Injury; Aldehyde Reductase; Animals; Apoptosis; Blotting, Western; Cytokines; Gene Expression Regulation; Imidazolidines; Kidney; Kidney Tubules; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; Neutrophils; Organ Specificity; Polymers; RNA, Messenger; Survival Analysis; Systemic Inflammatory Response Syndrome; Time Factors | 2012 |